Press Releases | 20 July 2021

bioLytical Laboratories Inc. Announces Dr. Joshua Eades as New Chief Scientific Officer

Read More »

News | 15 June 2021

The new normal: COVID-19 in a post-pandemic world

It is safe to say that COVID-19 has shifted how the world operates, with masks, constant handwashing, and social distancing now part of our regular vocabulary. Part of the “new normal” will likely include an increased focus on prevention and identifying immunity. As the pandemic shows signs of abating, it is worth assessing how businesses and individuals can begin to plan re-opening communities. Vaccines, continued safety protocols such as masking, and testing as critical pillars to re-opening global communities.

Read More »

News | 4 June 2021

Discover the I’m Ready Research Program. What is it all about?

June 2nd marked an exciting day in the history of our fight against HIV in Canada with the launch of the I’m Ready research program in Canada. This initiative is dedicated to ending HIV in Canada by scaling up access to testing and increasing connections to care.

Read More »

  • bioLytical® Laboratories develops and manufactures a rapid HIV diagnostic product, the INSTI® Kit. It is a unique, simple-to-use diagnostic kit used in the diagnosis of HIV infection. At 60 seconds for a reading, INSTI® Kit is the fastest HIV diagnostic assay in the world today. The INSTI® HIV-1/HIV-2 Antibody Test is a rapid in vitro qualitative test for the detection of antibodies to Human Immunodeficiency Virus Type 1 or Type 2 in human whole blood, fingerstick blood, or plasma.

    • You are currently viewing content for the Global region. Accept